Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of YAP-associated lncRNAs via RNA-binding protein immunoprecipitation sequencing (RIP-seq) experiments

ABSTRACT: Identification of YAP-associated lncRNAs via RNA-binding protein immunoprecipitation sequencing (RIP-seq) experiments

PROVIDER: PRJNA531678 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8870550_1.fastq.gz	Fastqsanger.gz
	SRR8870550_2.fastq.gz	Fastqsanger.gz
	SRR8870551_1.fastq.gz	Fastqsanger.gz
	SRR8870551_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Identification of YAP-associated lncRNAs via RNA-binding protein immunoprecipitation sequencing (RIP-seq) experiments

Project description:The analysis of the RNA-binding protein immunoprecipitation sequencing (RIP-seq) experiment is performed to identified YAP-specific binding lncRNAs.

2019-10-29 | GSE129535 | GEO

Human CELF4 RNA immunoprecipitation (RIP)

Project description:Human CELF4 RNA immunoprecipitation (RIP)

| PRJNA884998 | ENA

RNA-binding protein immunoprecipitation (RIP)and RNA sequencing

Project description:We report the result of lncRNAs binding to Hes1 in colon cancer SW480 cells using Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Millipore, MD, USA) following the manufacturer's instructions, the RNAs were analyzed by Illumina HiSeq 2500 Sequencing.

2019-07-20 | GSE134551 | GEO

RIP-sequence of IGF2BP3 in Ishikawa cells

Project description:To explain the possible molecular mechanism underlying the oncogenic roles of IGF2BP3 in EC, we employed RNA immunoprecipitation (RIP) assays to identify the lncRNAs involved in the regulation of IGF2BP3 function. RIP experiments, high-throughput sequencing and data analysis were performed by Seqhealth Tech (Wuhan, China). RIP assays were carried out on Ishikawa cells. The cells were lysed, and the lysis samples for immunoprecipitation reactions were incubated with anti-IGF2BP3 antibody (ab177477, Abcam, USA) or rabbit IgG (Cell Signaling Technology). The library products were enriched, quantified and finally sequenced on the Illumina PE150 platform.One hundred ninety-one candidates as IGF2BP3-interacting lncRNAs were identified in the RIP-seq results.

2022-03-16 | GSE198620 | GEO

Identification of Target LncRNAs of IMP1 in T47D Cells by RIP-Seq technique

Project description:IMP1 is a RNA binding protein shown to regulate translation, localization, or stability of their target RNAs. However, whether IMP1 can widely bind to lncRNAs and regulate their expression in Breast cancer cells remains to be confirmed. In this study, we used RNA binding protein immunoprecipitation-high throughput sequencing (RIP-Seq) technique to identify LncRNAs which bind to IMP1 protein in breast cancer cell line T47D cells.

2023-06-08 | GSE220087 | GEO

YAP/TAZ-dependent expression of lncRNAs

Project description:YAP/TAZ-dependent expression of lncRNAs

| PRJNA856876 | ENA

YAP/TAZ-dependent expression of lncRNAs [A549]

Project description:Body fluids from cancer patients are informative regarding disease conditions in tumor tissues. Thus, biomarkers detected by liquid biopsy can guide clinicians in designing personalized therapies and may serve as a proxy for treatment success. However, biomarkers that predict the existence of druggable target structures cannot be reliably defined in blood samples due to genetic tumor heterogeneity and presence of molecules from non-tumorous cells. To test the applicability of RNA signatures as liquid biopsy biomarkers, expression data from hepatocellular carcinoma (HCC) cells after inhibition of Hippo pathway effectors is investigated. We show that the oncogene yes-associated protein (YAP) transcriptionally controls a panel of long non-coding RNAs (lncRNAs), which support HCC progression via tumor cell-intrinsic mechanisms. These lncRNAs are detectable and overexpressed in YAPS127A transgenic mouse livers as well as in a subgroup of human HCC tissue and serum samples. Using a machine learning algorithm, a 4 gene lncRNA signature is defined that correlates with the nuclear abundance of YAP in HCC tissues (CYTOR, SNHG1, SNHG17, MIR4435-2HG). Importantly, YAP accumulation in human HCCs is significantly associated with lncRNA signature serum abundance in two independent patient cohorts. Evaluation of expression data and confirmatory experiments illustrate that the lncRNA signature is a robust predictor for YAP activity in other tumor types such as lung adenocarcinoma. Liquid biopsy-based detection of lncRNAs in cancer patients is informative for the activity of transcriptional regulators and can serve as diagnostic tool that guides clinicians in the design of targeted therapies.

2023-03-15 | GSE207723 | GEO

YAP/TAZ-dependent expression of lncRNAs [HLF]

2023-03-15 | GSE207722 | GEO

Aly/REF interacting lncRNAs and mRNAs by RNA immunoprecipitation (RIP)-sequencing in human abdominal aortic aneurysm tissue

Project description:Aly/REF interacting lncRNAs and mRNAs by RNA immunoprecipitation (RIP)-sequencing in human abdominal aortic aneurysm tissue

| PRJNA686949 | ENA

YAP/TAZ-dependent expression of lncRNAs [HLF]

Project description:YAP/TAZ-dependent expression of lncRNAs [HLF]

| PRJNA856881 | ENA